Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A final common pathway for depression: implications for therapy.

Eric A Stone1

  • 1Psychiatry, MHL HN510, NYU Medical Centre, New York, NY 10016, USA. eric.stone@nyu.edu

Expert Opinion on Therapeutic Targets
|August 2, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology.

Cancer research·2025
Same author

Protein evolution as a complex system.

Nature chemical biology·2025
Same author

Path2Omics: Enhanced transcriptomic and methylation prediction accuracy from tumor histopathology.

bioRxiv : the preprint server for biology·2025
Same author

Genome Biology of Rust Fungi.

Annual review of phytopathology·2025
Same author

Characterization of Virulence of <i>Puccinia coronata</i> f. sp. <i>avenae</i> in Australia in the 2023 Growing Season.

Plant disease·2025
Same author

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.

Nature cancer·2024
Same journal

The biological role of CCR4 and its ligands CCL17 and CCL22 in atopic dermatitis: therapeutic implications and future directions.

Expert opinion on therapeutic targets·2026
Same journal

Hepatocyte nuclear factor 4α - prospects for therapeutic targeting.

Expert opinion on therapeutic targets·2026
Same journal

The role of bile acid receptors in cholestatic liver disease: pathophysiological insights and therapeutic advances.

Expert opinion on therapeutic targets·2026
Same journal

Molecular insights for targeting the Nrf1 pathway in hepatocellular carcinoma.

Expert opinion on therapeutic targets·2026
Same journal

Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy.

Expert opinion on therapeutic targets·2026
Same journal

The AT<sub>2</sub> receptor as a potential target for autosomal dominant polycystic kidney disease therapy?

Expert opinion on therapeutic targets·2026
See all related articles

Depression involves reduced activity in reward brain areas and increased stress responses. Antidepressants reverse these changes, suggesting a new framework for understanding and treating this mood disorder.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Depression is characterized by hypoactivity in brain regions for positive motivation and hyperactivity in stress response regions.
  • These neural changes are reversed by antidepressant treatments.
  • This neural pattern may explain core depression symptoms: loss of motivation and increased stress.

Purpose of the Study:

  • To discuss a framework organizing diverse findings on depression's factors.
  • To propose new therapeutic strategies based on this neural framework.

Main Methods:

  • Review and synthesis of existing research on depression neurobiology.
  • Hypothetical therapeutic strategy development.

Main Results:

Related Experiment Videos

  • A unifying neural framework for depression symptoms.
  • Proposed novel therapeutic targets: low-dose corticosteroids and specific adrenoceptor modulators.

Conclusions:

  • The proposed neural framework effectively organizes depression research.
  • Novel therapeutic strategies targeting stress and motivational networks show promise for depression treatment.